CHRM2 and Graves disease: Autoantibodies towards the beta 1 (β1)-adrenergic and the M2 muscarinic receptors (in Graves’ disease) and elevated TH levels (in Graves’ disease and toxic nodular goitre) increase the risk for atrial fibrillation [11].